AI Science Tracker
EN

School of Medical Technology, Beijing Institute of Technology, Beijing, China

1 discovery from 2023

Discoveries

Artificial intelligence-based computer-aided diagnosis system supports diagnosis of lymph node metastasis in esophageal squamous cell carcinoma: A multicenter study

Source check: Source checked. Not independent scientific confirmation.

Finding: AI assistance increased expert accuracy 0.712→0.833 and specificity 0.697→0.891 for nodal metastasis diagnosis. Multicenter retrospective evaluation with two external hospital cohorts; no prospective outcome or treatment-benefit validation.

Technology: U-Net-based lesion segmentation and PET metabolic features support AI-assisted expert diagnosis of lymph-node metastasis

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
U-Net-based lesion segmentation and PET metabolic features support AI-assisted expert diagnosis of lymph-node metastasis
Test and result
AI assistance increased expert accuracy 0.712→0.833 and specificity 0.697→0.891 for nodal metastasis diagnosis.
Limitation / still unknown
Multicenter retrospective evaluation with two external hospital cohorts; no prospective outcome or treatment-benefit validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10009687/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.